204 related articles for article (PubMed ID: 10231869)
1. Combination growth hormone and estrogen increase bone mineralization in girls with Turner syndrome.
Beckett PR; Copeland KC; Flannery TK; Sherman LD; Abrams SA
Pediatr Res; 1999 May; 45(5 Pt 1):709-13. PubMed ID: 10231869
[TBL] [Abstract][Full Text] [Related]
2. Free dissociable insulin-like growth factor I (IGF-I), total IGF-I and their binding proteins in girls with Turner syndrome during long-term growth hormone treatment.
Bannink EM; van Doorn J; Stijnen T; Drop SL; de Muinck Keizer-Schrama SM
Clin Endocrinol (Oxf); 2006 Sep; 65(3):310-9. PubMed ID: 16918949
[TBL] [Abstract][Full Text] [Related]
3. Effect of growth hormone and 17beta-oestradiol treatment on metabolism and body composition in girls with Turner syndrome.
Gravholt CH; Hjerrild BE; Naeraa RW; Engbaek F; Mosekilde L; Christiansen JS
Clin Endocrinol (Oxf); 2005 May; 62(5):616-22. PubMed ID: 15853835
[TBL] [Abstract][Full Text] [Related]
4. Metabolic effects of oral versus transdermal estrogen in growth hormone-treated girls with turner syndrome.
Mauras N; Shulman D; Hsiang HY; Balagopal P; Welch S
J Clin Endocrinol Metab; 2007 Nov; 92(11):4154-60. PubMed ID: 17711924
[TBL] [Abstract][Full Text] [Related]
5. Optimizing estrogen replacement treatment in Turner syndrome.
Rosenfield RL; Perovic N; Devine N; Mauras N; Moshang T; Root AW; Sy JP
Pediatrics; 1998 Aug; 102(2 Pt 3):486-8. PubMed ID: 9685449
[TBL] [Abstract][Full Text] [Related]
6. Growth hormone and low dose estrogen in Turner syndrome: results of a United States multi-center trial to near-final height.
Quigley CA; Crowe BJ; Anglin DG; Chipman JJ
J Clin Endocrinol Metab; 2002 May; 87(5):2033-41. PubMed ID: 11994337
[TBL] [Abstract][Full Text] [Related]
7. Serum growth hormone (GH)-binding protein and insulin-like growth factor-I levels in Turner's syndrome before and during treatment with recombinant human GH and ethinyl estradiol.
Massa G; Bouillon R; Vanderschueren-Lodeweyckx M
J Clin Endocrinol Metab; 1992 Nov; 75(5):1298-302. PubMed ID: 1430092
[TBL] [Abstract][Full Text] [Related]
8. Salutary effects of combining early very low-dose systemic estradiol with growth hormone therapy in girls with Turner syndrome.
Rosenfield RL; Devine N; Hunold JJ; Mauras N; Moshang T; Root AW
J Clin Endocrinol Metab; 2005 Dec; 90(12):6424-30. PubMed ID: 16189255
[TBL] [Abstract][Full Text] [Related]
9. Evidence for early initiation of growth hormone and transdermal estradiol therapies in girls with Turner syndrome.
Davenport ML
Growth Horm IGF Res; 2006 Jul; 16 Suppl A():S91-7. PubMed ID: 16735135
[TBL] [Abstract][Full Text] [Related]
10. The effect of short term treatment with growth hormone and ethinyl estradiol on lower leg growth rate in girls with Turner's syndrome.
Ross JL; Cassorla F; Carpenter G; Long LM; Royster MS; Loriaux DL; Cutler GB
J Clin Endocrinol Metab; 1988 Sep; 67(3):515-8. PubMed ID: 3410937
[TBL] [Abstract][Full Text] [Related]
11. Growth hormone action in puberty: effects by gender.
Mauras N; Bishop K; Welch S
Growth Horm IGF Res; 2007 Dec; 17(6):463-71. PubMed ID: 17566776
[TBL] [Abstract][Full Text] [Related]
12. Morning versus evening administration of estradiol to girls with turner syndrome receiving growth hormone: impact on growth hormone and metabolism. A randomized placebo-controlled crossover study.
Naeraa RW; Gravholt CH; Kastrup KW; Svenstrup B; Christiansen JS
Acta Paediatr; 2001 May; 90(5):526-31. PubMed ID: 11430712
[TBL] [Abstract][Full Text] [Related]
13. Quantification of the adverse effect of ethinylestradiol containing oral contraceptive pills when used in conjunction with growth hormone replacement in routine practice.
Phelan N; Conway SH; Llahana S; Conway GS
Clin Endocrinol (Oxf); 2012 May; 76(5):729-33. PubMed ID: 22098528
[TBL] [Abstract][Full Text] [Related]
14. Homozygosity of the d3-growth hormone receptor polymorphism is associated with a high total effect of GH on growth and a low BMI in girls with Turner syndrome.
Binder G; Trebar B; Baur F; Schweizer R; Ranke MB
Clin Endocrinol (Oxf); 2008 Apr; 68(4):567-72. PubMed ID: 17973940
[TBL] [Abstract][Full Text] [Related]
15. Growth response and levels of growth factors after two years growth hormone treatment are similar for a once and twice daily injection regimen in girls with Turner syndrome. (Dutch Working Group on Growth Hormone).
van Teunenbroek A; de Muinck Keizer-Schrama S; Stijnen T; Waelkens J; Wit JM; Vulsma T; Gerver WJ; Reeser H; Delemarre-van de Waal H; Jansen M; Drop S
Clin Endocrinol (Oxf); 1997 Apr; 46(4):451-9. PubMed ID: 9196608
[TBL] [Abstract][Full Text] [Related]
16. The GH-IGF-IGFBP axis is changed in Turner syndrome: partial normalization by HRT.
Gravholt CH; Chen JW; Oxvig C; Overgaard MT; Christiansen JS; Frystyk J; Flyvbjerg A
Growth Horm IGF Res; 2006; 16(5-6):332-9. PubMed ID: 17067837
[TBL] [Abstract][Full Text] [Related]
17. Estrogen therapy enhances calcium absorption and retention and diminishes bone turnover in young girls with Turner's syndrome: a calcium kinetic study.
Mauras N; Vieira NE; Yergey AL
Metabolism; 1997 Aug; 46(8):908-13. PubMed ID: 9258273
[TBL] [Abstract][Full Text] [Related]
18. Turner syndrome and osteoporosis: mechanisms and prognosis.
Rubin K
Pediatrics; 1998 Aug; 102(2 Pt 3):481-5. PubMed ID: 9685448
[TBL] [Abstract][Full Text] [Related]
19. Carbohydrate metabolism during growth hormone treatment and after discontinuation of growth hormone treatment in girls with Turner syndrome treated with once or twice daily growth hormone injections.
Sas T; de Muinck Keizer-Schrama S; Aanstoot HJ; Stijnen T; Drop S
Clin Endocrinol (Oxf); 2000 Jun; 52(6):741-7. PubMed ID: 10848879
[TBL] [Abstract][Full Text] [Related]
20. Plasma growth hormone-binding protein activity, insulin-like growth factor I, and its binding protein levels in patients with Turner's syndrome: effect of short- and long-term recombinant human growth hormone administration.
Saggese G; Federico G; Cinquanta L
Pediatr Res; 1995 Jan; 37(1):106-11. PubMed ID: 7535419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
